URL copied
Bharat Biotech expects EUL from WHO for Covaxin in July- September
Bharat Biotech on Tuesday said it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Listing (EUL) during July-September. The company said regulatory approvals for Covaxin are in process in more than 60 countries including the USA, Brazil
and Hungary among others.
"Application for EUL has been submitted to WHO-Geneva. Regulatory approvals are expected during July-September 2021," it said in a release.
Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, according to WHO guidelines.